Congress Eyes Vaccine Pricing With Spotlight On Pfizer As COVID Boosters Look More Likely

Senate hearing offers early signals that US lawmakers will be closely watching how COVID-19 vaccine pricing evolves. Biden team pledges to try to make contracting more transparent.

More from Vaccines

More from Pink Sheet